In Organovo's financial conference call today, Keith Murphy, Organovo’s chief executive officer, indicated that “response to the exVive3D Human Liver Tissue has been strong, and in line with our expectations.  We continue to expect this tissue to grow into the tens of millions in annual revenue, and that it has $100M+ revenue potential.

Keith Murphy, CEO of Organovo, stated that his company will be able to 3D print partial organs within the next 4-6 years. These partial organs could be used to repair damaged organs, such as the liver, providing valuable time to patients as they await a full transplant.

ElectroMaterials researcher Cathal O'Connell believes that while hollow organs, such as the bladder, were printed a decade ago, printing ‘solid organs’, such as the kidney or the liver, are still probably a couple of decades into the future.